Gene · 2042
Papers1,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | JCI Insight | 2023 | 37581938 | PubTator, text mining | PubMed |
| EphrinB2: Expression of a novel potential target in renal cell carcinoma. | Indian J Urol | 2023 | 37575160 | PubTator, text mining | PubMed |
| EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets. | Cancers (Basel) | 2023 | 37568780 | PubTator, text mining | PubMed |
| Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37555981 | PubTator, text mining | PubMed |
| spinDrop: a droplet microfluidic platform to maximise single-cell sequencing information content. | Nat Commun | 2023 | 37553326 | PubTator, text mining | PubMed |
| Decoding the prognostic significance of integrator complex subunit 9 (INTS9) in glioma: links to TP53 mutations, E2F signaling, and inflammatory microenvironments. | Cancer Cell Int | 2023 | 37537630 | PubTator, text mining | PubMed |
| Colorectal cancer-associated mutations impair EphB1 kinase function. | J Biol Chem | 2023 | 37527777 | PubTator, text mining | PubMed |
| Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. | BMC Med Genomics | 2023 | 37525171 | PubTator, text mining | PubMed |
| Molecular profiling reveals potential targets in cholangiocarcinoma. | World J Gastroenterol | 2023 | 37476584 | PubTator, text mining | PubMed |
| mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection. | Front Immunol | 2023 | 37457694 | PubTator, text mining | PubMed |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development. | Diagnostics (Basel) | 2023 | 37443631 | PubTator, text mining | PubMed |
| The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells. | J Exp Clin Cancer Res | 2023 | 37434266 | PubTator, text mining | PubMed |
| Membrane recruitment of the polarity protein Scribble by the cell adhesion receptor TMIGD1. | Commun Biol | 2023 | 37430142 | PubTator, text mining | PubMed |
| Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients. | Transl Lung Cancer Res | 2023 | 37425402 | PubTator, text mining | PubMed |
| UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. | Nat Commun | 2023 | 37407562 | PubTator, text mining | PubMed |
| Development of a high-fidelity Cas9-dependent adenine base editor (ABE) system for genome editing with high-fidelity Cas9 variants. | Genes Dis | 2023 | 37396512 | PubTator, text mining | PubMed |
| YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer. | Can Respir J | 2023 | 37388902 | PubTator, text mining | PubMed |
| Pleiotropy of autism-associated chromatin regulators. | Development | 2023 | 37366052 | PubTator, text mining | PubMed |
| A 20-gene mutation signature predicts the efficacy of immune checkpoint inhibitor therapy in advanced non-small cell lung cancer patients. | BMC Pulm Med | 2023 | 37349743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2042/papers?page=8